Anti-Amnesic Effect of Curculigo orchioides Plant Extract and Its Function on Acetylcholinesterase Enzyme
European Journal of Medicinal Plants,
Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, and one of the most predominant causes of dementia in older people. Preventing acetylcholine from breakdown by an excess amount of acetylcholinesterase is a proven therapy for AD. Traditionally Curculigo orchioides is known for its antioxidant activity, enzyme inhibition activity, and other medicinal uses. In this study, in vitro acetylcholinesterase, inhibitory activity was investigated, and methanolic extract of the plant showed significant activity. This study aims to investigate cholinesterase inhibitory activity, learning, and memory-enhancing activity of Curculigo orchioides.
Materials and Methods: The crude methanol extract of the dried powder was prepared by the cold extraction method. In-vitro acetylcholinesterase (AChE) inhibitory activities were determined by the modified Ellman’s method. To confirm learning and memory-enhancing effects, the scopolamine-induced memory impairment Swiss-albino mice were used, and to find the anti-amnesic effect of the extract, a passive shock avoidance task was applied.
Results: Results proved that scopolamine-induced cognitive dysfunction decreased significantly by administration of the plant extract solution in the passive avoidance task, and inhibited brain acetylcholinesterase activity. While running an in-vitro AChE inhibitory test the IC50 was 0.782±0.067μg/ml.
Conclusion: The results suggested that methanolic extract of Curculigo orchioides can inhibit AChE in-vitro. Besides this, it provides data that proves its ability to improve whole brain AChE activity and enhance memory.
- Curculigo orchioides
- cholinesterase inhibitor
- passive avoidance
- alzheimer’s disease
How to Cite
García-Ayllón MS, Small DH, Avila J, Sáez-Valero J. Revisiting the role of acetylcholinesterase in Alzheimer’s disease: cross-talk with P-tau and β-amyloid. Frontiers in molecular neuroscience. 2011;13;4-22.
Petrov KA, Kharlamova AD, Lenina OA, Nurtdinov AR, Sitdykova ME, Ilyin VI, Zueva IV, Nikolsky EE. Specific inhibition of acetylcholinesterase as an approach to decrease muscarinic side effects during myasthenia gravis treatment. Scientific reports. 2018;8(1):1-10.
Mohammad D, Chan P, Bradley J, Lanctôt K, Herrmann N. Acetylcholinesterase inhibitors for treating dementia symptoms-a safety evaluation. Expert opinion on drug safety. 2017;16(9):1009-19.
Saxena M, Dubey R. Target enzyme in Alzheimer’s disease: Acetylcholinesterase inhibitors. Current topics in medicinal chemistry. 2019;19(4):264-75.
Mahdavi M, Saeedi M, Gholamnia L, Jeddi SA, Sabourian R, Shafiee A, Foroumadi A, Akbarzadeh T. Synthesis of novel tacrine analogs as acetylcholinesterase inhibitors. Journal of Heterocyclic Chemistry. 2017;54(1):384-90.
Galimberti D, Scarpini E. Old and new acetylcholinesterase inhibitors for Alzheimer’s disease. Expert opinion on investigational drugs. 2016;25(10): 1181-7.
Jiang Y, Gao H, Turdu G. Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer’s disease: a review. Bioorganic chemistry. 2017;75:50-61.
Biswas K, Azad AK, Sultana T, Khan F, Hossain S, Alam S, Chowdhary R, Khatun Y. Assessment of In-vitro cholinesterase inhibitory and thrombolytic potential of bark and seed extracts of Tamarindus indica (L.) relevant to the treatment of Alzheimer’s disease and clotting disorders. Journal of intercultural ethnopharmacology. 2017;6(1):115.
Uddin MJ, Alam MN, Biswas K, Rahman MA. In vitro antioxidative and cholinesterase inhibitory properties of Thunbergia grandiflora leaf extract. Cogent Food & Agriculture. 2016;2(1):1256929.
Biswas K, Hossain S, Alam S, Sultana T, Khan F, Dutta S. In-vitro Assessment of cholinesterase inhibitory and thrombolytic activity of six available citrus fruits in Bangladesh: Relevant for Treating Neurodegenerative Disorder. European Journal of Medicinal Plants. 2018;5:1-1.
Castillo-Ordoñez WO, Cajas-Salazar N. Acetylcholinesterase inhibitory agents in plants and their application to dementia: Alzheimer's disease. In Diagnosis and Management in Dementia. 2020;10(1):631-645
Kim JK, Park SU. Pharmacological aspects of galantamine for the treatment of Alzheimer's disease. EXCLI journal. 2017;16:35.
Kaufmann D, Kaur Dogra A, Tahrani A, Herrmann F, Wink M. Extracts from traditional Chinese medicinal plants inhibit acetylcholinesterase, a known Alzheimer’s disease target. Molecules. 2016 ;21(9):1161.
Biswas K, Islam A, Sharmin T, Biswas PK. In-vitro cholinesterase inhibitory activity of dry fruit extract of Phyllanthus emblica relevant to the treatment of Alzheimer’s disease. J Phytopharmacol. 2015;4:5-8.
He Y, Dong X, Jia X, Li M, Yuan T, Xu H, Qin L, Han T, Zhang Q. Qualitative and quantitative analysis on chemical constituents from Curculigo orchioides using ultra high performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry. Journal of pharmaceutical and biomedical analysis. 2015;102:236-45.
Wang N, Zhao G, Zhang Y, Wang X, Zhao L, Xu P, Shou D. A network pharmacology approach to determine the active components and potential targets of Curculigo orchioides in the treatment of osteoporosis. Medical science monitor: international medical journal of experimental and clinical research. 2017;23:5113.
Jagtap S. Phytochemmical screening and antioxidant activity of tuberous rhizome extracts of Curculigo orchioides gaertn.(Kali Musali). European Journal of Biomedical. 2016;3(6):289-93.
Hejazi II, Khanam R, Mehdi SH, Bhat AR, Rizvi MM, Thakur SC, Athar F. Antioxidative and anti-proliferative potential of Curculigo orchioides gaertn in oxidative stress induced cytotoxicity: In vitro, ex vivo and in silico studies. Food and chemical toxicology. 2018;115: 244-59.
Zuo AX, Shen Y, Jiang ZY, Zhang XM, Zhou J, Lü J, Chen JJ. Two new triterpenoid glycosides from Curculigo orchioides. Journal of Asian natural products research. 2012;14(5):407-12.
Venkatachalam P, Kayalvizhi T, Udayabanu J, Benelli G, Geetha N. Enhanced antibacterial and cytotoxic activity of phytochemical loaded-silver nanoparticles using Curculigo orchioides leaf extracts with different extraction techniques. Journal of Cluster Science. 2017;28(1):607-19.
Lv TT, Ju CG, Liu BN, Ren XH, Shan GS, Jia TZ. Determination of orcinol glucoside by LC-MS in Curculigo orchioides and its application to a pharmacokinetic study. Revista Brasileira de Farmacognosia. 2020;29:744-8.
Gulati V, Gulati P, Harding IH, Palombo EA. Exploring the anti-diabetic potential of Australian aboriginal and Indian ayurvedic plant extracts using cell-based assays. BMC complementary and alternative medicine. 2015;15(1):1-11.
Kumar P, Shukla SK. Effect of Curculigo orchioides in experimental hepatotoxicity in cockerels. Journal of Pharmacognosy and Phytochemistry. 2019;8(1):1012-6.
Zhao Y, Guo Y, Chen Y, Liu S, Wu N, Jia D. Curculigoside attenuates myocardial ischemia reperfusion injury by inhibiting the opening of the mitochondrial permeability transition pore. International journal of molecular medicine. 2020;45(5):1514-24.
Dingova D, Leroy J, Check A, Garaj V, Krejci E, Hrabovska A. Optimal detection of cholinesterase activity in biological samples: Modifications to the standard Ellman’s assay. Analytical biochemistry. 2014;462:67-75.
Ögren SO, Stiedl O. Passive avoidance. Encyclopedia of psychopharmacology. 2010;2:960-7.
Khan RA, Khan MR, Sahreen S. Brain antioxidant markers, cognitive performance and acetylcholinesterase activity of rats: Efficiency of Sonchus asper. Behavioral and Brain functions. 2012;8(1):1-7.
Ranjan N, Kumari M. Acetylcholinesterase inhibition by medicinal plants: A review. Annals of Plant Sciences. 2017;6(06):1640-4.
Miguel MG. Antioxidant and anti-inflammatory activities of essential oils: A short review. Molecules. 2010;15(12):9252-87.
Getova D, Mihaylova A. Effects of Rhodiola rosea extract on passive avoidance tests in rats. Open Medicine. 2013;8(2):176-81.
Abstract View: 151 times
PDF Download: 50 times